John Lunec

9PUBLICATIONS
13CO-AUTHORS
Cancer geneticsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2026
Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. <i>Cancers</i> 2021, <i>13</i>, 3876.

Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang

|Jan 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating <i>TP53</i> Wild-Type Chronic Lymphocytic Leukemia.

Erhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis

|Dec 25, 2024
A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers.

M Zanjirband, M H Nasr-Esfahani, N J Curtin

|Jul 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic Leukemia.

Erhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis

|Apr 10, 2024
Combination p53 activation and BCL-x<sub>L</sub>/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.

Hayden L Bell, Helen J Blair, Samantha J Jepson Gosling

|Jul 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.

Erhan Aptullahoglu, Jonathan P Wallis, Helen Marr

Pageof 2

Frequent Collaborators

4 joint publications

Elaine Willmore

3 joint publications

Erhan Aptullahoglu

2 joint publications

Chiao-En Wu

1 joint publications

M Zanjirband